Search results for "geriatric"

showing 10 items of 1602 documents

Adult age differences in inhibitory processes and their predictive validity for fluid intelligence.

2008

According to the inhibition-deficit hypothesis age differences in working memory capacity and fluid intelligence have been attributed to a decline in inhibitory efficiency. Conceptualizing inhibition as multifaceted, 88 participants (49 younger and 39 elderly) completed two versions of the negative priming paradigm (identification and localization), and two variants of the directed forgetting paradigm (listwise and itemwise). Two tasks of the Wechsler Intelligence Test with high loadings on general fluid intelligence (Gf) served as validation criteria. Results revealed task-specific and speed-independent inhibitory deficits in the elderly (lower negative priming in both paradigms; more intr…

Predictive validityAdultMaleAgingPsychometricsIntelligenceRepetition primingExperimental and Cognitive PsychologyTest validitybehavioral disciplines and activitiesDevelopmental psychologyYoung AdultCognitionReaction TimeHumansAgedAged 80 and overPsychological TestsWorking memoryWechsler Adult Intelligence ScaleCognitionPsychiatry and Mental healthNeuropsychology and Physiological PsychologyMemory Short-TermNegative primingFemaleGeriatrics and GerontologyPsychologypsychological phenomena and processesNeuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition
researchProduct

Construct and predictive validity of a self-reported measure of preclinical mobility limitation.

2007

Abstract Manty M, Heinonen A, Leinonen R, Tormakangas T, Sakari-Rantala R, Hirvensalo M, von Bonsdorff MB, Rantanen T. Construct and predictive validity of a self-reported measure of preclinical mobility limitation. Objectives To validate self-reported preclinical mobility limitation concept and self-report assessment method against muscle power and walking speed, and to study the predictive validity of preclinical mobility limitation with respect to future risk of manifest mobility limitation. Design Observational prospective cohort study and cross-sectional analysis. Setting Research laboratory and community. Participants A total of 632 community-living (age range, 75−81y) women and men t…

Predictive validityMalemedicine.medical_specialtyActivities of daily livingCross-sectional studymedicine.medical_treatmentPsychological interventionPhysical Therapy Sports Therapy and RehabilitationDisability EvaluationPhysical medicine and rehabilitationPredictive Value of TestsRisk FactorsSurveys and QuestionnairesActivities of Daily LivingmedicineHumansProspective StudiesGeriatric AssessmentAgedAged 80 and overRehabilitationRehabilitationPreferred walking speedCross-Sectional StudiesMobility LimitationPhysical therapyObservational studyFemaleMorbidityPsychologyLocomotionFollow-Up StudiesArchives of physical medicine and rehabilitation
researchProduct

Cognitive impairment and stroke in elderly patients.

2016

Daniele Lo Coco,1 Gianluca Lopez,1 Salvatore Corrao,2,31Neurology and Stroke Unit, 2Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, 3Centre of Research for Effectiveness and Appropriateness in Medicine (C.R.E.A.M.), Di.Bi.M.I.S., University of Palermo, Palermo, Italy Abstract: We reviewed current knowledge about the interaction between stroke and vascular risk factors and the development of cognitive impairment and dementia. Stroke is increasingly recognized as an important cause of cognitive problems and has been implicated in the development of both Alzheimer's disease and vascular dementia. Th…

Preventive Health ServiceGerontologylcsh:Diseases of the circulatory (Cardiovascular) systemAgingEndocrinology Diabetes and MetabolismDiseaseReview0302 clinical medicineCognitionRisk FactorsPreventive Health ServicesPrevalenceMedicineAge FactorPharmacology (medical)030212 general & internal medicineCognitive declineStrokeAged 80 and overAge FactorsCognitionHematologyGeneral MedicinePrognosiscerebrovascular diseaseStrokeCardiology and Cardiovascular MedicineRisk assessmentHumanPrognosielderlyRisk AssessmentVascular risk factorAging; Cerebrovascular disease; Cognitive function; Dementia; Vascular risk factors; Age Factors; Aged; Aged 80 and over; Aging; Cognition Disorders; Geriatric Assessment; Humans; Prevalence; Preventive Health Services; Prognosis; Quality of Life; Risk Assessment; Risk Factors; Stroke; Cognition; Cardiology and Cardiovascular Medicine; Pharmacology (medical); Public Health Environmental and Occupational Health; Hematology; Endocrinology Diabetes and MetabolismCognition Disorder03 medical and health sciencesDementiaHumansCognitive rehabilitation therapyVascular dementiaGeriatric Assessmentcognitive functioncognitive impairmentAgedbusiness.industryRisk FactorPublic Health Environmental and Occupational Healthmedicine.diseaselcsh:RC666-701vascular risk factorsQuality of LifebusinessCognition Disorders030217 neurology & neurosurgerydementiaVascular health and risk management
researchProduct

P4–286: Secretion of the soluble APP ectodomain (APPS) is not affected by the non–steroidal anti–inflammatory drugs ibuprofen and indomethacin in pri…

2006

Primary (chemistry)Epidemiologybusiness.industryHealth PolicyPharmacologyIbuprofenPsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceNon steroidal anti inflammatoryEctodomainmedicineSecretionNeurology (clinical)Geriatrics and Gerontologybusinessmedicine.drugAlzheimer's & Dementia
researchProduct

Older Adult Mentors and Youth at Risk: Challenges for Intergenerational Mentoring Programs in Family-Centered Cultures

2012

This article poses some preliminary reflections about the viability of youth mentoring schemes in family-centered cultural contexts based on a pilot experience developed in Spain within the framework of a project aiming to train older adults as youth mentors in five European countries. After an introduction to the field of intergenerational mentoring, a description of the pilot program follows, with special attention paid to the development of the Spanish local project. Drawing on the project evaluation, some open questions are posed regarding (a) the optimal institutional framing for an intergenerational mentoring program and (b) the challenge with social representation of the mentor role.

Program evaluationArcheologySociology and Political ScienceSocial PsychologyYouth mentoringComputingMilieux_GENERALFraming (social sciences)Social representationPedagogyPilot programSociologyGeriatrics and GerontologyLife-span and Life-course StudiesSocial Sciences (miscellaneous)Journal of Intergenerational Relationships
researchProduct

The Cleavage Product of Amyloid-β Protein Precursor sAβPPα Modulates BAG3-Dependent Aggresome Formation and Enhances Cellular Proteasomal Activity

2015

Alzheimer's disease (AD) is the major age-associated form of dementia characterized by gradual cognitive decline. Aberrant cleavage of the amyloid-β protein precursor (AβPP) is thought to play an important role in the pathology of this disease. Two principal AβPP processing pathways exist: amyloidogenic cleavage of AβPP resulting in production of the soluble N-terminal fragment sAβPPβ, amyloid-β (Aβ), which accumulates in AD brain, and the AβPP intracellular domain (AICD) sAβPPα, p3 and AICD are generated in the non-amyloidogenic pathway. Prevalence of amyloidogenic versus non-amyloidogenic processing leads to depletion of sAβPPα and an increase in Aβ. Although sAβPPα is a well-accepted neu…

Proteasome Endopeptidase ComplexTime FactorsCell SurvivalLeupeptinsGreen Fluorescent ProteinsCysteine Proteinase InhibitorsProtein degradationProtein aggregationBiologyTransfectionBAG3Rats Sprague-DawleyAmyloid beta-Protein PrecursorAnimalsHumansRNA MessengerRNA Small InterferingProtein precursorCells CulturedAdaptor Proteins Signal TransducingNeuronsAmyloid beta-PeptidesDose-Response Relationship DrugGeneral NeuroscienceHEK 293 cellsBrainGeneral MedicineFibroblastsEmbryo MammalianRatsCell biologyPsychiatry and Mental healthClinical PsychologyHEK293 CellsProteostasisAggresomeGene Expression RegulationBiochemistryProteasomeProteolysisAmyloid Precursor Protein SecretasesGeriatrics and GerontologyApoptosis Regulatory ProteinsJournal of Alzheimer's Disease
researchProduct

2019

Active aging has been established as a policy goal for aging societies. We define active aging at the individual level as striving for elements of well-being through activities in relation to a person’s goals, functional capacities and opportunities. Increasing evidence suggests that any meaningful activity is beneficial for different aspects of well-being in older people. The aim of the present randomized controlled trial is to test the feasibility and effectiveness of a one-year community-based intervention on active aging. The AGNES intervention aims at increasing older peoples’ participation in self-selected valued activities. The proposed study is a two-arm single-blinded randomized co…

Protocol (science)GerontologyRehabilitationRandomizationbusiness.industrymedicine.medical_treatmentBehavior change3. Good healthTest (assessment)law.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled triallawIntervention (counseling)medicine030212 general & internal medicineGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryBMC Geriatrics
researchProduct

[S2‐01‐01]: Alpha‐secretase as a therapeutic target

2005

Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceAlpha secretaseEpidemiologyChemistryHealth PolicyCancer researchNeurology (clinical)Geriatrics and GerontologyAlzheimer's & Dementia
researchProduct

O1‐11‐06: Presenilin is the molecular target of both acidic and non‐acidic gamma‐secretase modulators

2012

Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceBiochemistryEpidemiologyChemistryHealth PolicyMolecular targetsNeurology (clinical)Geriatrics and GerontologyGamma secretasePresenilinAlzheimer's & Dementia
researchProduct

O1‐06‐07: Misprocessing of Multiple Transmembrane Substrates Reveals Gamma‐Secretase Dysfunction in Both Familial and Sporadic Alzheimer's Diseases

2009

Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceEpidemiologyHealth PolicyCancer researchNeurology (clinical)Geriatrics and GerontologyBiologyTransmembrane proteinGamma secretaseAlzheimer's & Dementia
researchProduct